Evidence map›Paper›PMID 38917287›Full record

ArticleIEEE journal of biomedical and health informatics2024

A Telemedicine Analytic Framework for Fully and Semi-Automatic Alzheimer's Disease Screening Using Clock Drawing Test.

Wei Bo, Suzanne S Sullivan, Xiaoyu Zhang, Mingchen Gao, Wenyao Xu

Abstract read
In one paragraph

Article in IEEE journal of biomedical and health informatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wei Bo
Suzanne S Sullivan
Xiaoyu Zhang
Mingchen Gao
Wenyao Xu

Funding

The National Health and Trends StudyU01AG032947 · NIA · JOHNS HOPKINS UNIVERSITY · PI VICKI A. FREEDMAN, JENNIFER ANN SCHRACK · 2008 to 2026
$169.4M
A Longitudinal Examination to Predict Quality of Life and Care Transitions for Persons with Alzheimer’s Disease and Related Dementias at End-of-LifeR03AG067159 · NIA · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI SULLIVAN, SUZANNE SIERRA · 2020 to 2021
$160k
NIA NIH HHS R03 AG067159NIA NIH HHS U01 AG032947
6 · The paper itself

Abstract

More than 6 million Americans are at risk for Alzheimer's Disease Related Dementias (ADRD), most of whom are 65 or older. The clock drawing test (CDT) is a quick, simple, and effective technique that has the potential advantage of self-management and screening for ADRD patients. Current CDT-based ADRD screening studies focus more on efficacy, involving many handcrafted features, ignoring data modalities, and lacking validation. This paper aims to propose a unified telemedicine framework for fully and semi-automatic effective early ADRD screening based on multimodal and agile data fusion, focusing on the interpretability and validation of the model by using gradient-weighted class activation mapping (Grad-CAM) and locally linear embedding (LLE). The datasets for this work include 1,662 samples of CDT images and related demographic and cognitive information. The fully automatic case involving only CDT images can achieve the highest AUC of 81 with a 75 recall rate in binary screening. The multimodal data fusion in the semi-automatic case can achieve up to 90 AUC with an 83 recall rate. The visualization of the Convolutional Neural Networks (CNNs) shows that it can automatically obtain critical information about the outline, scale, and clock hands from CDT images, and the analysis of structured features shows that the memory test is key to effective ADRD screening.

Indexed as

Alzheimer DiseaseImage Interpretation, Computer-AssistedNeuropsychological TestsTelemedicineAgedAged, 80 and overFemaleHumansMale

Identifiers

PMID38917287
PMCPMC11668910

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.